Dr. Chang-Halpenny is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7130 N Millbrook Ave
Ste 100
Fresno, CA 93720Phone+1 559-326-1222Fax+1 559-326-1230
Education & Training
- Kaiser Permanente Southern California (Los Angeles)Residency, Radiation Oncology, 2013 - 2017
- Santa Clara Valley Medical CenterInternship, Transitional Year, 2011 - 2012
- Stanford University School of MedicineClass of 2011
Certifications & Licensure
- CA State Medical License 2012 - 2026
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- ASTRO AdvocacyDay Travel Award ASTRO, 2015
- American College of Radiation Oncology (ACRO) Travel Award ACRO, 2015
- Radiological Society of North America (RSNA) Trainee Research Prize,Medical Student Category RSNA, 2008
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsSequential versus “sandwich” sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinomaSharon M. Lu, Christine N. Chang-Halpenny, Julie Hwang-Graziano
Gynecologic Oncology. 2015-04-01 - 6 citationsEarly-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.Christine N. Chang-Halpenny, Sathima Natarajan, Julie Hwang-Graziano
American Journal of Clinical Oncology. 2016-03-04 - 25 citationsEarly stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.Christine N. Chang-Halpenny, Sathima Natarajan, Julie Hwang-Graziano
Gynecologic Oncology. 2013-12-01
Journal Articles
- Outcomes of modestly hypofractionated radiation for lung tumors: pre- and mid-treatment positron emission tomography-computed tomography metrics as prognostic factorsHarris J, Chang-Halpenny C, Maxim PG, Quon A, Graves EE, Diehn M, Loo, BW, Clinical Lung Cancer, 1/31/2015
- Elderly Patients with Glioblastoma Multiforme Treated with Concurrent Temozolomide and Standard versus Abbreviated Course RadiotherapyChang-Halpenny CN, Yeh J, Lien W, The Permanente Journal, 1/1/2015
- Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumorsTrakul N, Chang CN, Harris J, Chapman C, Rao A, Shen J, Quinlan-Davidson S, Filion EJ, Wakelee HA, Colevas AD, Whyte RI, Dieterich S, Maxim PG, Hristov D, Tran P, Le Q..., Int J Radiat Oncol Biol Phys, 9/1/2012
- Join now to see all
Grant Support
- Stanford Medical Scholars Research Grants (2 awarded)Stanford Medical SchoolPresent
- Stanford Undergraduate Research Major GrantStanford UniversityPresent
Committees
- Subcommittee Member, ARRO Social Media and Website 2014 - Present
Research History
- Kaiser Permanente Southern California Radiation Oncology, PIs Dr J Hwang, Dr W Lien, Dr J Rahimian, Dr A RaoProjects on GBM, uterine papillary serous carcinoma, uterine clear cell carcinoma, radiosurgery (AVM), treatment planning (radiosurgery technique via VMAT)2012 - Present
- Stanford Radiation Oncology, PI Dr Bill LooClinical research on RT, SABR and PET CT for non-small cell lung cancer2008 - 2009
- Stanford Department of Anesthesia, PI Dr Andrew PattersonHeart failure and beta-adrenergic receptors, basic science laboratory, full time 2006-2007. Included genotyping, pressure-volume loop calculation, cellular assays.2006 - 2007
Professional Memberships
- Member
- Member
- American College of Radiation Oncology (ACRO)Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: